迪瑞医疗
(300396)
| 流通市值：31.56亿 | | | 总市值：31.61亿 |
| 流通股本：2.72亿 | | | 总股本：2.73亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 205,104,204.65 | 309,590,005.1 | 235,006,915.29 | 498,568,460.52 |
| 结算备付金 | 0 | 0 | - | - |
| 拆出资金 | 0 | 0 | - | - |
| 交易性金融资产 | 180,617,638.89 | 180,321,361.11 | 277,189,815.28 | 70,131,347.22 |
| 衍生金融资产 | 0 | 0 | - | - |
| 应收票据及应收账款 | 180,034,040.21 | 195,852,963.63 | 336,579,941.1 | 395,837,230.82 |
| 其中：应收票据 | 0 | 158,200 | 771,593.12 | - |
| 应收账款 | 180,034,040.21 | 195,694,763.63 | 335,808,347.98 | 395,837,230.82 |
| 应收款项融资 | 0 | 0 | - | - |
| 预付款项 | 15,843,448.56 | 12,251,152.59 | 13,910,113.45 | 13,812,222.6 |
| 应收保费 | 0 | 0 | - | - |
| 应收分保账款 | 0 | 0 | - | - |
| 应收分保合同准备金 | 0 | 0 | - | - |
| 其他应收款合计 | 32,458,881.23 | 32,309,859.19 | 5,567,911.02 | 6,986,074.57 |
| 其中:应收利息 | 0 | 0 | - | - |
| 应收股利 | 0 | 0 | - | - |
| 买入返售金融资产 | 0 | 0 | - | - |
| 存货 | 551,305,044.29 | 568,008,347.54 | 498,844,931.93 | 526,877,964.76 |
| 合同资产 | 0 | 0 | - | - |
| 一年内到期的非流动资产 | 148,754,511.85 | 147,419,039.29 | 165,755,376.83 | 160,173,487.08 |
| 其他流动资产 | 265,651,595.77 | 273,671,118.45 | 177,821,898.47 | 160,986,422.14 |
| 流动资产合计 | 1,579,769,365.45 | 1,719,423,846.9 | 1,710,676,903.37 | 1,833,373,209.71 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | 0 | - | - |
| 债权投资 | 0 | 0 | - | - |
| 其他债权投资 | 0 | 0 | - | - |
| 长期应收款 | 80,763,096.48 | 89,075,786.05 | 117,496,408.99 | 145,799,776.73 |
| 长期股权投资 | 450,890,654.62 | 447,049,951.64 | 446,351,230.11 | 437,660,894.94 |
| 其他权益工具投资 | 108,216,800 | 108,216,800 | 117,382,800 | 117,382,800 |
| 其他非流动金融资产 | 0 | 0 | - | - |
| 投资性房地产 | 43,971,515.42 | 44,467,077.55 | 45,753,442.7 | 46,258,456.67 |
| 固定资产 | 181,778,782.56 | 185,230,747.94 | 188,349,400.02 | 186,305,837.96 |
| 在建工程 | 2,715,826.65 | 2,715,826.65 | 901,667.35 | 900,797.35 |
| 生产性生物资产 | 0 | 0 | - | - |
| 油气资产 | 0 | 0 | - | - |
| 使用权资产 | 8,327,783.7 | 6,874,293.47 | 8,069,824.18 | 9,448,354.79 |
| 无形资产 | 51,351,373.85 | 54,287,831.62 | 62,459,019.49 | 63,550,614.92 |
| 开发支出 | 17,004,224.3 | 16,525,162.89 | 30,665,531.4 | 29,870,191.51 |
| 商誉 | 0 | 0 | - | - |
| 长期待摊费用 | 26,212,202.05 | 27,749,767.43 | 9,104,654.04 | 10,080,718.19 |
| 递延所得税资产 | 61,319,649.98 | 61,095,009.92 | 25,307,012.25 | 21,574,214.23 |
| 其他非流动资产 | 9,444,137.6 | 9,371,557.45 | 22,323,195.97 | 58,864,684.54 |
| 非流动资产合计 | 1,041,996,047.21 | 1,052,659,812.61 | 1,074,164,186.5 | 1,127,697,341.83 |
| 资产总计 | 2,621,765,412.66 | 2,772,083,659.51 | 2,784,841,089.87 | 2,961,070,551.54 |
| 流动负债: | | | | |
| 短期借款 | 0 | 80,053,777.78 | 180,000,000 | 179,500,000 |
| 向中央银行借款 | 0 | 0 | - | - |
| 吸收存款及同业存放 | 0 | 0 | - | - |
| 拆入资金 | 0 | 0 | - | - |
| 交易性金融负债 | 0 | 0 | - | - |
| 衍生金融负债 | 0 | 0 | - | - |
| 应付票据及应付账款 | 133,434,559.84 | 167,246,838.61 | 194,936,742.08 | 311,118,309.8 |
| 其中：应付票据 | 63,731,054.6 | 111,029,840.75 | 116,574,755.15 | 183,431,270.9 |
| 应付账款 | 69,703,505.24 | 56,216,997.86 | 78,361,986.93 | 127,687,038.9 |
| 预收款项 | 100,396.77 | 53,305.09 | 48,758.15 | 15,711.55 |
| 合同负债 | 400,504,138.43 | 410,844,549.52 | 38,582,229.96 | 38,051,408.16 |
| 卖出回购金融资产款 | 0 | 0 | - | - |
| 应付手续费及佣金 | 0 | 0 | - | - |
| 应付职工薪酬 | 31,648,368.83 | 41,249,856.79 | 16,930,608.01 | 10,389,804.85 |
| 应交税费 | 3,448,470.19 | 2,765,147.56 | 3,550,993.36 | 3,853,086.58 |
| 其他应付款合计 | 63,739,508.46 | 76,679,187.81 | 34,380,993.02 | 39,400,893.28 |
| 其中:应付利息 | 0 | 0 | - | - |
| 应付股利 | 0 | 0 | - | - |
| 应付分保账款 | 0 | 0 | - | - |
| 保险合同准备金 | 0 | 0 | - | - |
| 代理买卖证券款 | 0 | 0 | - | - |
| 代理承销证券款 | 0 | 0 | - | - |
| 一年内到期的非流动负债 | 322,932,471.97 | 125,642,198.31 | 6,480,327.73 | 7,170,742.18 |
| 其他流动负债 | 47,555,818.61 | 49,737,783.24 | 3,269,437.68 | 3,885,693.13 |
| 流动负债合计 | 1,003,363,733.1 | 954,272,644.71 | 478,180,089.99 | 593,385,649.53 |
| 非流动负债: | | | | |
| 长期借款 | 44,600,000 | 243,464,178.75 | 363,200,000 | 363,800,000 |
| 应付债券 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 租赁负债 | 3,757,358.72 | 1,835,590.05 | 3,078,536.41 | 4,096,833.68 |
| 长期应付款 | 0 | 0 | - | - |
| 长期应付职工薪酬 | 0 | 0 | - | - |
| 预计负债 | 0 | 0 | - | - |
| 递延收益 | 19,379,138.4 | 19,625,364.97 | 18,746,591.54 | 17,367,818.11 |
| 递延所得税负债 | 15,707,290.33 | 16,036,017.23 | 25,832,251.86 | 26,081,279.02 |
| 其他非流动负债 | 0 | 0 | - | - |
| 非流动负债合计 | 83,443,787.45 | 280,961,151 | 410,857,379.81 | 411,345,930.81 |
| 负债合计 | 1,086,807,520.55 | 1,235,233,795.71 | 889,037,469.8 | 1,004,731,580.34 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 272,700,161 | 272,700,161 | 272,700,161 | 272,700,161 |
| 其他权益工具 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 资本公积 | 243,616,718.29 | 243,616,718.29 | 243,616,718.29 | 243,616,718.29 |
| 减:库存股 | 0 | 0 | - | - |
| 其他综合收益 | 36,900,390.61 | 37,645,213.4 | 44,739,162.08 | 46,338,807.74 |
| 专项储备 | 0 | 0 | - | - |
| 盈余公积 | 137,986,102.82 | 137,986,102.82 | 137,986,102.82 | 137,986,102.82 |
| 一般风险准备 | 0 | 0 | - | - |
| 未分配利润 | 843,759,982.66 | 844,897,594.77 | 1,196,747,867.77 | 1,255,689,844.05 |
| 归属于母公司股东权益合计 | 1,534,963,355.38 | 1,536,845,790.28 | 1,895,790,011.96 | 1,956,331,633.9 |
| 少数股东权益 | -5,463.27 | 4,073.52 | 13,608.11 | 7,337.3 |
| 股东权益合计 | 1,534,957,892.11 | 1,536,849,863.8 | 1,895,803,620.07 | 1,956,338,971.2 |
| 负债和股东权益合计 | 2,621,765,412.66 | 2,772,083,659.51 | 2,784,841,089.87 | 2,961,070,551.54 |
| 公告日期 | 2026-04-30 | 2026-04-30 | 2025-10-28 | 2025-08-26 |
| 审计意见(境内) | | 保留意见 | | |